Welcome to our dedicated page for Lifemd news (Ticker: LFMD), a resource for investors and traders seeking the latest updates and insights on Lifemd stock.
LifeMD, Inc. provides virtual primary care through a direct-to-patient telehealth platform that combines telemedicine, laboratory access, pharmacy services, a 50-state affiliated medical group, an affiliated pharmacy and a U.S.-based patient care center. Company news commonly covers its Telehealth operating segment, recurring subscription revenue, patient sign-ups, gross margin trends and guidance.
Recurring updates also address LifeMD’s specialized care areas, including primary care, men’s and women’s health, weight management and hormone therapy. News items feature GLP-1 weight management offerings such as Wegovy and Foundayo, branded therapy access through manufacturer programs, preferred stock dividends, executive leadership changes and investor conference participation.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
LifeMD, Inc. (NASDAQ: LFMD) has launched new membership plans aimed at enhancing access to virtual primary care services. The innovative features in the proprietary mobile app now allow consumers to download it for free, gain access to a symptom checker, a discounted prescription card, and a live appointment queue for immediate virtual consultations. The company is introducing three membership tiers: FlexCare, which requires no membership fee; TotalCare, a quarterly plan that includes monthly visits; and ConciergeCare, which offers unlimited visits with a dedicated doctor. The expansion of these services is anticipated to support ongoing membership growth and positions LifeMD favorably in the evolving telehealth market, expected to see significant disruption by 2030 according to Bain and Co.
LifeMD, Inc. (NASDAQ: LFMD/LFMDP) announced a cash dividend of $0.5546875 per share on its 8.875% Series A Cumulative Perpetual Preferred Stock (LFMDP). The dividend will be paid on April 17, 2023, to shareholders on record as of April 7, 2023. This move reflects the company's commitment to providing returns to its preferred shareholders. LifeMD is a telehealth provider that offers a range of virtual healthcare services across the United States, leveraging a proprietary technology platform and nationwide pharmacy network to enhance healthcare accessibility.
LifeMD reported a significant milestone in Q4 2022, achieving consolidated Adjusted EBITDA profitability for the first time, totaling $631,000. Full Year 2022 consolidated revenue reached $119.0 million, a 28% increase year-over-year, despite a $2.9 million impact from deferred telehealth shipments in Q4. The company executed a $40 million debt financing agreement with Avenue Capital, bolstering its capital position for future growth. Guidance for 2023 indicates projected revenue of $140-$150 million and Adjusted EBITDA of $12-$18 million. Notably, active telehealth subscribers grew by 22% to approximately 169,000.
LifeMD (NASDAQ: LFMD) announced securing a senior secured credit facility with Avenue Capital, providing up to $40 million, including an initial $15 million. This financing aims to support the company’s strategic growth and profitability plans, with expectations of eliminating cash burn soon. The credit agreement includes an 18-month interest-only period and a growth option up to $20 million. Additionally, LifeMD issued warrants to Avenue Capital for purchasing shares at $1.24. This investment is expected to bolster LifeMD's financial flexibility and maintain its majority interest in WorkSimpli, projected to generate over 20% EBITDA margins in 2023.